AWM
CVS icon

Avior Wealth Management’s CVS Health CVS Stock Holding History

Avior Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Buy
3,167
+3
+0.1% +$268 0.01% 634
2026
Q1 		$227K Buy
3,164
+216
+7% +$16.6K 0.01% 763
2025
Q4 		$234K Buy
+2,948
New +$232K 0.01% 687
2025
Q1 		– Sell
-1,934
Closed -$86.8K – 1101
2024
Q4 		$86.8K Buy
1,934
+181
+10% +$10.2K ﹤0.01% 947
2024
Q3 		$110K Sell
1,753
-4,662
-73% -$272K ﹤0.01% 856
2024
Q2 		$379K Sell
6,415
-8,643
-57% -$541K 0.02% 507
2024
Q1 		$1.2M Buy
15,058
+7,019
+87% +$536K 0.06% 247
2023
Q4 		$635K Buy
8,039
+332
+4% +$23.6K 0.04% 292
2023
Q3 		$538K Sell
7,707
-22
-0.3% -$1.56K 0.04% 306
2023
Q2 		$534K Sell
7,729
-300
-4% -$21.3K 0.03% 321
2023
Q1 		$597K Buy
8,029
+3,736
+87% +$313K 0.04% 299
2022
Q4 		$400K Buy
4,293
+356
+9% +$34.4K 0.03% 352
2022
Q3 		$375K Buy
3,937
+107
+3% +$10.6K 0.03% 334
2022
Q2 		$354K Sell
3,830
-681
-15% -$66.5K 0.04% 323
2022
Q1 		$455K Buy
4,511
+101
+2% +$10.6K 0.04% 312
2021
Q4 		$454K Buy
4,410
+1
+0% +$92 0.04% 338
2021
Q3 		$373K Sell
4,409
-291
-6% -$24.4K 0.03% 355
2021
Q2 		$391K Buy
4,700
+4,289
+1,044% +$351K 0.04% 334
2021
Q1 		$30K Sell
411
-23
-5% -$1.68K ﹤0.01% 577
2020
Q4 		$29K Sell
434
-18
-4% -$1.17K ﹤0.01% 559
2020
Q3 		$26K Sell
452
-252
-36% -$15.7K ﹤0.01% 560
2020
Q2 		$45K Buy
704
+110
+19% +$6.93K 0.01% 493
2020
Q1 		$35K Buy
594
+455
+327% +$30.4K 0.01% 475
2019
Q4 		$10K Buy
139
+100
+256% +$7.02K ﹤0.01% 599
2019
Q3 		$2K Sell
39
-122
-76% -$7.23K ﹤0.01% 676
2019
Q2 		$9K Sell
161
-4,836
-97% -$260K ﹤0.01% 605
2019
Q1 		$268K Hold
4,997
– – 0.06% 300
2018
Q4 		$327K Buy
4,997
+1,172
+31% +$87.5K 0.08% 231
2018
Q3 		$301K Buy
3,825
+3,693
+2,798% +$264K 0.06% 259
2018
Q2 		$8K Sell
132
-19
-13% -$1.25K ﹤0.01% 602
2018
Q1 		$9K Sell
151
-84
-36% -$6.03K ﹤0.01% 589
2017
Q4 		$17K Sell
235
-144
-38% -$10.5K ﹤0.01% 559
2017
Q3 		$31K Buy
379
+86
+29% +$6.8K 0.01% 247
2017
Q2 		$24K Sell
293
-189
-39% -$14.9K 0.01% 243
2017
Q1 		$38K Sell
482
-80
-14% -$6.39K 0.01% 250
2016
Q4 		$44K Sell
562
-1,115
-66% -$90.2K 0.02% 222
2016
Q3 		$149K Buy
1,677
+1,202
+253% +$113K 0.06% 147
2016
Q2 		$45K Buy
475
+52
+12% +$5.18K 0.02% 217
2016
Q1 		$44K Sell
423
-248
-37% -$24.1K 0.02% 219
2015
Q4 		$66K Buy
671
+1
+0.1% +$98 0.04% 163
2015
Q3 		$65K Buy
670
+252
+60% +$26.5K 0.04% 156
2015
Q2 		$44K Buy
418
+1
+0.2% +$102 0.03% 139
2015
Q1 		$43K Buy
417
+1
+0.2% +$101 0.03% 143
2014
Q4 		$40K Buy
416
+2
+0.5% +$176 0.03% 148
2014
Q3 		$33K Buy
414
+231
+126% +$18.2K 0.03% 157
2014
Q2 		$14K Sell
183
-191
-51% -$14.4K 0.01% 217
2014
Q1 		$28K Buy
+374
New +$26.4K 0.02% 167

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Avior Wealth Management's CVS Position: Q2 2026 in Review

Avior Wealth Management increased its CVS Health (CVS) stake by 0.09% in Q2 2026, buying an estimated $268 and bringing the position to 3,167 shares worth $328K. The position accounts for 0.01% of the portfolio, ranked #634.

Avior Wealth Management first reported a position in CVS in Q1 2014 and has held it in 47 quarters since. The position peaked at $1.2M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Avior Wealth Management held 3,167 shares of CVS Health worth $328K as of Q2 2026.
  • Avior Wealth Management bought 3 CVS Health shares in Q2 2026, an estimated $268.
  • CVS Health made up 0.01% of Avior Wealth Management's portfolio in Q2 2026, its #634 holding.
  • Avior Wealth Management first reported a position in CVS Health in Q1 2014 and has held it in 47 quarters since.
  • Avior Wealth Management's CVS Health position peaked at $1.2M in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.